61 related articles for article (PubMed ID: 24447864)
1. Correlation of cytokines and inducible nitric oxide synthase expression with prognostic factors in ovarian cancer.
Martins Filho A; Jammal MP; Côbo Ede C; Silveira TP; Adad SJ; Murta EF; Nomelini RS
Immunol Lett; 2014; 158(1-2):195-9. PubMed ID: 24447864
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
3. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome.
Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
Gynecol Oncol; 2004 Mar; 92(3):806-12. PubMed ID: 14984945
[TBL] [Abstract][Full Text] [Related]
4. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical visualization of pro-inflammatory cytokines and enzymes in ovarian tumors.
Plewka D; Kowalczyk AE; Jakubiec-Bartnik B; Morek M; Bogunia E; Kmiec A; Wierzbicki PM; Plewka A
Folia Histochem Cytobiol; 2014; 52(2):124-37. PubMed ID: 25007180
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of iNOS in epithelial ovarian cancer.
Anttila MA; Voutilainen K; Merivalo S; Saarikoski S; Kosma VM
Gynecol Oncol; 2007 Apr; 105(1):97-103. PubMed ID: 17174383
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.
Aaltoma SH; Lipponen PK; Kosma VM
Anticancer Res; 2001; 21(4B):3101-6. PubMed ID: 11712818
[TBL] [Abstract][Full Text] [Related]
8. Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer.
Sanguinete MMM; Oliveira PH; Martins-Filho A; Micheli DC; Tavares-Murta BM; Murta EFC; Nomelini RS
Immunol Invest; 2017 Oct; 46(7):677-688. PubMed ID: 28872976
[TBL] [Abstract][Full Text] [Related]
9. IL-6 and IL-8 as Prognostic Factors in Peritoneal Fluid of Ovarian Cancer.
Rodrigues ISS; Martins-Filho A; Micheli DC; Lima CA; Tavares-Murta BM; Murta EFC; Nomelini RS
Immunol Invest; 2020 Jul; 49(5):510-521. PubMed ID: 31755326
[TBL] [Abstract][Full Text] [Related]
10. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
11. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of cytokine induced nitric oxide synthase in colorectal carcinoma.
Nozoe T; Yasuda M; Honda M; Inutsuka S; Korenaga D
Oncol Rep; 2002; 9(3):521-4. PubMed ID: 11956620
[TBL] [Abstract][Full Text] [Related]
13. Stromal IL2 is related to the neutrophil/lymphocyte ratio in epithelial ovarian cancer.
Santos TD; Jammal MP; Silveira TP; Murta EFC; Nomelini RS
Pathologica; 2019 Jun; 111(2):62-66. PubMed ID: 31388197
[TBL] [Abstract][Full Text] [Related]
14. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
[TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase expression and its prognostic significance in colorectal cancer.
Zafirellis K; Zachaki A; Agrogiannis G; Gravani K
APMIS; 2010 Feb; 118(2):115-24. PubMed ID: 20132175
[TBL] [Abstract][Full Text] [Related]
16. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of second-look laparotomy for surgically confirmed early-stage epithelial ovarian cancer: a multicenter retrospective study.
Sato N; Akahira J; Kitamura T; Aoki M; Yoshinaga K; Okamura C; Utsunomiya H; Shimizu T; Niikura H; Ito K; Okamura K; Yaegashi N
Int J Clin Oncol; 2003 Feb; 8(1):40-4. PubMed ID: 12601541
[TBL] [Abstract][Full Text] [Related]
18. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.
Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR; Blumenson LE
Cancer; 1997 Sep; 80(5):892-8. PubMed ID: 9307189
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of COX-2 and survivin expression in ovarian cancer.
Athanassiadou P; Grapsa D; Athanassiades P; Gonidi M; Athanassiadou AM; Tsipis A; Patsouris E
Pathol Res Pract; 2008; 204(4):241-9. PubMed ID: 18171606
[TBL] [Abstract][Full Text] [Related]
20. [Inducible nitric oxide synthase and basic fibroblast growth factor expression as prognostic factors in supraglottic squamous cell carcinoma].
Huang Z; Zeng ZY; Peng HW; Xia LP; Hou JH
Ai Zheng; 2003 Sep; 22(9):978-81. PubMed ID: 12969533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
